{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:36:41Z","timestamp":1783154201199,"version":"3.54.6"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.carrev.2016.11.011","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T14:48:29Z","timestamp":1480344509000},"page":"226-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antiplatelet therapy in patients with glucose-6-phosphate dehydrogenases deficiency after percutaneous coronary intervention: A reappraisal for clinical and interventional cardiologists"],"prefix":"10.1016","volume":"18","author":[{"given":"Marco","family":"Zuin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Rigatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paola","family":"Galasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Dell'Avvocata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"Roncon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2016.11.011_bb0005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jcpt.12262","article-title":"Antiplatelet and invasive treatment in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency and acute coronary syndrome. The safety of aspirin","volume":"40","author":"Kafkas","year":"2015","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.carrev.2016.11.011_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.5551\/jat.29371","article-title":"Dual antiplatelet therapy in patients with glucose-6-phosphate dehydrogenase deficiency undergoing PCI with drug-eluting stents","volume":"22","author":"Biscaglia","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.carrev.2016.11.011_bb0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"371","author":"Cappellini","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2016.11.011_bb0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s001090050253","article-title":"Glucose-6-phosphate dehydrogenase deficiency and malaria","volume":"76","author":"Ruwende","year":"1998","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.carrev.2016.11.011_bb0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/(SICI)1096-8652(199602)51:2<174::AID-AJH18>3.0.CO;2-I","article-title":"Acute hemolytic anemia precipitated by myocardial infarction and pericardial tamponade in G6PD deficiency","volume":"51","author":"Lee","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.carrev.2016.11.011_bb0030","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2459\/JCM.0b013e32831103c3","article-title":"Drug-eluting stents in a patient with favism: is the aspirin administration safe?","volume":"9","author":"Rigattieri","year":"2008","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.carrev.2016.11.011_bb0035","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijcard.2012.08.024","article-title":"Dual anti-platelet therapy in patients with G6PD deficiency after percutaneous coronary intervention","volume":"165","author":"Pappas","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2016.11.011_bb0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.5551\/jat.6858","article-title":"Glucose-6-phosphate dehydrogenase (G6PDH) deficiency in a patient with ST-segment elevation acute myocardial infarction successfully treated by simple thrombectomy","volume":"18","author":"Porto","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.carrev.2016.11.011_bb0045","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu283","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2016.11.011_bb0050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s10545-008-0704-5","article-title":"Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease","volume":"31","author":"Meloni","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.carrev.2016.11.011_bb0055","doi-asserted-by":"crossref","first-page":"H491","DOI":"10.1152\/ajpheart.00721.2012","article-title":"Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease","volume":"304","author":"Hecker","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838916303347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838916303347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:12:29Z","timestamp":1761559949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838916303347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1553838916303347"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2016.11.011","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiplatelet therapy in patients with glucose-6-phosphate dehydrogenases deficiency after percutaneous coronary intervention: A reappraisal for clinical and interventional cardiologists","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2016.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}